Monthly Archives: February 2016

Weekly Roundup 2.19.16

There hasn’t been a Weekly Roundup for the past few weeks, but news has been slow and life has not, so apologies. It seems the shorter days of Winter make it more challenging for me to get all the things … Continue reading

Posted in Weekly Roundup | Tagged , | Comments Off on Weekly Roundup 2.19.16

This is Your State – This is Your State on Drugs

In years gone by, I have taken occasion to write a posting with this title to take a look at the policy activity that is going on at the state level that impacts medicines. It has been a few years … Continue reading

Posted in Legislation | Comments Off on This is Your State – This is Your State on Drugs

10 Years of Eye on FDA – Looking Back

This month marks a decade of Eye on FDA. A good friend of mine was writing a personal blog, which most blogs were back then, that was well-written and funny and I thought – hey I could do that only … Continue reading

Posted in Current Affairs | Comments Off on 10 Years of Eye on FDA – Looking Back

From HIV to Zika – The Role of Communications

The pathogen may change, but there are aspects of communications during a time of outbreak, particularly involving an emerging pathogen, that seem to be a constant. A few short months ago no one had ever heard of the Zika virus. … Continue reading

Posted in Current Affairs | Comments Off on From HIV to Zika – The Role of Communications

FDA Guidance Output Plans for 2016

While there has been focus on what FDA accomplished in 2015 – and there will continue to be some of that – it is also a great time to look ahead. What can we anticipate for 2016? This month several … Continue reading

Posted in FDA Policy | Comments Off on FDA Guidance Output Plans for 2016